So they do need to mix the pfιzєr concoction.
Here are the instructions.
Not rocket science at all.
Any Walgreen's employee could follow these simple instructions.
It's not like it's life or death or anything...
DOSAGE AND ADMINISTRATION Storage and Handling During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light. Do not refreeze thawed vials. Frozen Vials Prior to Use Cartons of pfιzєr-BioNTech CÖVÌD-19 ναccιnє Multiple Dose Vials arrive in thermal containers with dry ice. Once received, remove the vial cartons immediately from the thermal container and preferably store in an ultra-low temperature freezer between -80ºC to -60ºC (-112ºF to -76ºF) until the expiry date printed on the label. Alternatively, vials may be stored at -25°C to -15°C (-13°F to 5°F) for up to 2 weeks. Vials must be kept frozen and protected from light until ready to use. Vials stored at -25°C to -15°C (-13°F to 5°F) for up to 2 weeks may be returned one time to the recommended storage condition of -80ºC to -60ºC (-112ºF to -76ºF). Total cumulative time the vials are stored at -25°C to -15°C (-13°F to 5°F) should be tracked and should not exceed 2 weeks. If an ultra-low temperature freezer is not available, the thermal container in which the pfιzєr-BioNTech CÖVÌD-19 ναccιnє arrives may be used as temporary storage when consistently re-filled to the top of the container with dry ice. Refer to the re-icing guidelines packed in the original thermal container for instructions regarding the use of the thermal container for temporary storage. The thermal container maintains a temperature range of -90ºC to -60ºC (-130ºF to -76ºF). Storage of the vials between -96°C to -60°C (-141°F to -76°F) is not considered an excursion from the recommended storage condition. Transportation of Frozen Vials If local redistribution is needed and full cartons containing vials cannot be transported at -90°C to -60°C (-130°F to -76°F), vials may be transported at -25°C to -15°C (-13°F to 5°F). Any hours used for transport at -25°C to -15°C (-13°F to 5°F) count against the 2-week limit for storage at -25°C to -15°C (-13°F to 5°F). Frozen vials transported at -25°C to -15°C (-13°F to 5°F) may be returned one time to the recommended storage condition of -80ºC to -60ºC (-112ºF to -76ºF). Thawed Vials Before Dilution Thawed Under Refrigeration Thaw and then store undiluted vials in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)] for up to 5 days (120 hours). A carton of 25 vials or 195 vials may take up to 2 or 3 hours, respectively, to thaw in the refrigerator, whereas a fewer number of vials will thaw in less time. Revised: 06 April 2021 3 Thawed at Room Temperature For immediate use, thaw undiluted vials at room temperature [up to 25ºC (77ºF)] for 30 minutes. Thawed vials can be handled in room light conditions. Vials must reach room temperature before dilution. Undiluted vials may be stored at room temperature for no more than 2 hours. Transportation of Thawed Vials Available data support transportation of one or more thawed vials at 2°C to 8°C (35°F to 46°F) for up to 12 hours. Any hours used for transport at 2°C to 8°C (35°F to 46°F) count against the 120-hour limit for storage at 2°C to 8°C (35°F to 46°F). Vials After Dilution • After dilution, store vials between 2°C to 25°C (35°F to 77°F) and use within 6 hours from the time of dilution. • During storage, minimize exposure to room light, and avoid exposure to direct sunlight and ultraviolet light. • Any ναccιnє remaining in vials must be discarded after 6 hours. • Do not refreeze. Dosing and Schedule The pfιzєr-BioNTech CÖVÌD-19 ναccιnє is administered intramuscularly as a series of two doses (0.3 mL each) 3 weeks apart. There are no data available on the interchangeability of the pfιzєr-BioNTech CÖVÌD-19 ναccιnє with other CÖVÌD-19 ναccιnєs to complete the vaccination series. Individuals who have received one dose of pfιzєr-BioNTech CÖVÌD-19 ναccιnє should receive a second dose of pfιzєr-BioNTech CÖVÌD-19 ναccιnє to complete the vaccination series. Dose Preparation Prior to Dilution • The pfιzєr-BioNTech CÖVÌD-19 ναccιnє Multiple Dose Vial contains a volume of 0.45 mL, supplied as a frozen suspension that does not contain preservative. Each vial must be thawed and diluted prior to administration. • Vials may be thawed in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)] or at room temperature [up to 25ºC (77ºF)] (see Storage and Handling). • Refer to thawing instructions in the panels below. Dilution Dilute the vial contents using 1.8 mL of 0.9% Sodium Chloride Injection, USP (not provided) to form the pfιzєr-BioNTech CÖVÌD-19 ναccιnє. ONLY use 0.9% Sodium Chloride Injection, USP as the diluent. This diluent is not packaged with the ναccιnє Revised: 06 April 2021 4 and must be sourced separately. Do not use bacteriostatic 0.9% Sodium Chloride Injection or any other diluent. Do not add more than 1.8 mL of diluent. After dilution, one vial contains 6 doses of 0.3 mL. Vial labels and cartons may state that after dilution, a vial contains 5 doses of 0.3 mL. The information in this Fact Sheet regarding the number of doses per vial after dilution supersedes the number of doses stated on vial labels and cartons. • Refer to dilution and dose preparation instructions in the panels below. THAWING PRIOR TO DILUTION • Thaw vial(s) of pfιzєr-BioNTech CÖVÌD-19 ναccιnє before use either by: o Allowing vial(s) to thaw in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)]. A carton of vials may take up to 3 hours to thaw, and thawed vials can be stored in the refrigerator for up to five days (120 hours). o Allowing vial(s) to sit at room temperature [up to 25ºC (77ºF)] for 30 minutes. • Using either thawing method, vials must reach room temperature before dilution and must be diluted within 2 hours. • Before dilution invert ναccιnє vial gently 10 times. • Do not shake. • Inspect the liquid in the vial prior to dilution. The liquid is a white to offwhite suspension and may contain white to off-white opaque amorphous particles. • Do not use if liquid is discolored or if other particles are observed. Revised: 06 April 2021 5 DILUTION • Obtain sterile 0.9% Sodium Chloride Injection, USP. Use only this as the diluent. • Using aseptic technique, withdraw 1.8 mL of diluent into a transfer syringe (21-gauge or narrower needle). • Cleanse the ναccιnє vial stopper with a single-use antiseptic swab. • Add 1.8 mL of 0.9% Sodium Chloride Injection, USP into the ναccιnє vial. • Equalize vial pressure before removing the needle from the vial by withdrawing 1.8 mL air into the empty diluent syringe. • Gently invert the vial containing the pfιzєr-BioNTech CÖVÌD-19 ναccιnє 10 times to mix. • Do not shake. • Inspect the ναccιnє in the vial. • The ναccιnє will be an off-white suspension. Do not use if ναccιnє is discolored or contains particulate matter. Revised: 06 April 2021 6 • Record the date and time of dilution on the pfιzєr-BioNTech CÖVÌD-19 ναccιnє vial label. • Store between 2°C to 25°C (35°F to 77°F). • Discard any unused ναccιnє 6 hours after dilution. PREPARATION OF INDIVIDUAL 0.3 mL DOSES OF pfιzєr-BIONTECH CÖVÌD-19 ναccιnє • Using aseptic technique, cleanse the vial stopper with a single-use antiseptic swab, and withdraw 0.3 mL of the pfιzєr-BioNTech CÖVÌD-19 ναccιnє preferentially using a low dead-volume syringe and/or needle. • Each dose must contain 0.3 mL of ναccιnє. • If the amount of ναccιnє remaining in the vial cannot provide a full dose of 0.3 mL, discard the vial and any excess volume. • Administer immediately. Administration Visually inspect each dose in the dosing syringe prior to administration. The ναccιnє will be an off-white suspension. During the visual inspection, • verify the final dosing volume of 0.3 mL. • confirm there are no particulates and that no discoloration is observed. • do not administer if ναccιnє is discolored or contains particulate matter. Administer the pfιzєr-BioNTech CÖVÌD-19 ναccιnє intramuscularly. After dilution, vials of pfιzєr-BioNTech CÖVÌD-19 ναccιnє contain six doses of 0.3 mL of ναccιnє. Low dead-volume syringes and/or needles can be used to extract six doses from a single vial. If standard syringes and needles are used, there may not be sufficient volume to extract a sixth dose from a single vial. Irrespective of the type of syringe and needle: Revised: 06 April 2021 7 • Each dose must contain 0.3 mL of ναccιnє. • If the amount of ναccιnє remaining in the vial cannot provide a full dose of 0.3 mL, discard the vial and content. • Do not pool excess ναccιnє from multiple vials. Contraindications Do not administer pfιzєr-BioNTech CÖVÌD-19 ναccιnє to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the pfιzєr-BioNTech CÖVÌD-19 ναccιnє (see Full EUA Prescribing Information).
This post has the leaflets for all the different brands.https://nonvenipacem.com/page/2/
You know, the leaflet they hand you AFTER you've been shot.
Oh and of course we know they reported in the media that it's fine to mix and match the brands. Fresh out of one kind which has to be stored at arctic temps, just go back in and take the other kind that doesn't.
There are no contraindications after all.
You know all those silly warnings at the end of ads for any kind of drug on tv.
Could cause this, could cause that, ask your doctor if you have this or that...
This miracle drug is a one size fits all for everyone on the planet!